For the third time in 15 months, the FDA is warning healthcare providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety.
FDA spars with recalcitrant compounding pharmacy, again
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.